Raphael Galleh

Dr. Raphael Galleh is an active researcher at Aston University specializing in antimicrobial development, biofilm research, and glycobiology. His work bridges immunology, virology, and dentistry with significant contributions to understanding infection mechanisms and novel therapeutic approaches.

Education:

• PhD in Understanding glycans and glycosidases in infection and biofilm formation (University of Sheffield, 2023)
• MSc in Antibiofilm Activity of plant extracts against Pseudomonas aeruginosa (Ahmadu Bello University, 2015)
• BSc in Antimicrobial activities of Tricholoma magnivelare mushroom on MRSA (2010)

His research focuses on developing novel antimicrobials through glycobiology and phytotherapy, with particular emphasis on biofilm disruption, Helicobacter pylori pathogenesis, and urinary catheter-associated infections. Recent work explores DNA photocleavage agents and sialidase inhibitors for periodontal disease.

Analysis of his publications reveals strong interdisciplinary trends combining chemistry, microbiology, and clinical applications, with significant work on Nigerian population health studies and natural product research.

Scientific Recognition:

• ORCID: 0000-0003-2541-4851
• Research fingerprint includes Nasarawa State studies, urinary catheter infections, and Aloe vera phytochemistry

His collaborative network spans international institutions with recent work showing significant Mendeley readership (up to 20 readers) and X (Twitter) engagement (up to 7 posts). Research demonstrates practical applications in antimicrobial resistance and biofilm-related infections.

Active in laboratory-based research focusing on glycans, glycosidases, and plant-derived antimicrobials, with ongoing studies in DNA interaction agents and bacterial enzyme inhibition.